Sign In
Buy RIGL
$30.30
+0.280 (+0.93%)
At Close: Jun 03, 2026
Top Penny Stocks to Buy in July? 7 You May Not Know About
04:06pm, Monday, 28'th Jun 2021
Looking for penny stocks to buy in July 2021? Here's 7 for your watchlist The post Top Penny Stocks to Buy in July?
Rigel Pharmaceuticals: A Patented FDA Approved Drug That May Successfully Fight COVID-19
08:23am, Monday, 14'th Jun 2021
Rigel Pharmaceuticals: A Patented FDA Approved Drug That May Successfully Fight COVID-19
Rigel to Present at the Jefferies Virtual Healthcare Conference
07:30am, Wednesday, 26'th May 2021
SOUTH SAN FRANCISCO, Calif., May 26, 2021 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is sched
Rigel Appoints Alison L. Hannah, M.D.
07:30am, Friday, 14'th May 2021
SOUTH SAN FRANCISCO, Calif., May 14, 2021 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has appointed Alison L.
RIGL Stock: 11.82% Increase (From $3.47 To $3.88) Pre-Market Explanation
06:42am, Thursday, 06'th May 2021
The stock price of Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) increased from 11.82% (from $3.47 to $3.88) pre-market. This is why it happened.
Rigel Pharmaceuticals, Inc. (RIGL) CEO Raul Rodriguez on Q1 2021 Results - Earnings Call Transcript
10:49pm, Wednesday, 05'th May 2021
Rigel Pharmaceuticals, Inc. (RIGL) CEO Raul Rodriguez on Q1 2021 Results - Earnings Call Transcript
Rigel Pharmaceuticals (RIGL) Tops Q1 Earnings and Revenue Estimates
07:10pm, Wednesday, 05'th May 2021
Rigel (RIGL) delivered earnings and revenue surprises of 2100.00% and 102.24%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Rigel Reports First Quarter 2021 Financial Results and Provides Business Update
04:01pm, Wednesday, 05'th May 2021
SOUTH SAN FRANCISCO, Calif., May 5, 2021 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the first quarter ended March 31, 2021, including sales of TA
Rigel Announces Conference Call and Webcast to Report First Quarter 2021 Financial Results and Business Update
07:30am, Wednesday, 28'th Apr 2021
SOUTH SAN FRANCISCO, Calif., April 28, 2021 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its first quarter 2021 financial results after market close
Rigel Pharmaceuticals: Escalating Value Drivers Improve Upside Potential
01:08pm, Friday, 23'rd Apr 2021
Rigel Pharmaceuticals has four value drivers that could generate substantial revenue growth and have limited downside risk. It appears as if the market has failed to recognize the potential upside. TA
Why Rigel Pharmaceuticals Stock Jumped Today
04:02pm, Tuesday, 13'th Apr 2021
The company announced positive results from an important COVID-19 clinical study.
RIGL Stock: Over 15% Increase Pre-Market Explanation
08:07am, Tuesday, 13'th Apr 2021
The stock price of Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) increased by over 15% pre-market. This is why it happened.
SOUTH SAN FRANCISCO, Calif., April 13, 2021 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced positive topline results from a multi-center, Phase 2 clinical trial to evaluate
Rigel Announces Closing of Strategic Collaboration with Lilly
07:30am, Wednesday, 07'th Apr 2021
SOUTH SAN FRANCISCO, Calif., April 7, 2021 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the successful closing of its license agreement with Eli Lilly and Company (Lilly)
Rigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients
07:30am, Thursday, 11'th Mar 2021
SOUTH SAN FRANCISCO, Calif., March 11, 2021 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the completion of patient enrollment in a multi-center Phase 2 clinical trial t
